Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms.

M Nadji, S Z Tabei, A Castro

    Cancer
    |September 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Search for long-lived doubly charged Higgs bosons in pp collisions at sqrt[s] = 1.96 TeV.

    Physical review letters·2005
    Same author

    Measurement of B(t --> Wb)/B(t--> Wq) at the collider detector at fermilab.

    Physical review letters·2005
    Same author

    Search for new physics using high-mass tau pairs from 1.96 TeV pp collisions.

    Physical review letters·2005
    Same author

    Multiple primary digital apocrine sweat gland carcinosarcoma in a cat.

    The Veterinary record·2005
    Same author

    Measurement of the W(+)W(-) production cross section in pp collisions at square root[s]=1.96 TeV using dilepton events.

    Physical review letters·2005
    Same author

    Search for anomalous kinematics in tt dilepton events at CDF II.

    Physical review letters·2005

    Researchers developed a new diagnostic marker for prostate cancer using antiserum to human prostate-specific antigen. This immunohistochemical stain accurately identifies prostate tumors, offering a valuable tool for histologic diagnosis.

    Area of Science:

    • Oncology
    • Immunohistochemistry
    • Urologic Pathology

    Background:

    • Accurate histologic diagnosis of prostate tumors is crucial for effective patient management.
    • Existing diagnostic markers, such as prostatic acid phosphatase, have limitations.
    • There is a need for novel immunohistochemical markers specific to prostate epithelium.

    Purpose of the Study:

    • To evaluate the utility of antiserum to human prostate-specific antigen (PSA) as a diagnostic marker for prostatic tumors.
    • To determine the specificity and sensitivity of this marker in distinguishing prostatic malignancies from nonprostatic neoplasms.

    Main Methods:

    • Raising antiserum to human PSA in rabbits.
    • Utilizing immunoperoxidase staining techniques on tissue samples.

    Related Experiment Videos

  • Comparing staining results between prostatic and nonprostatic tumors.

    • Main Results:

    • All primary and metastatic prostatic malignancies demonstrated positive staining.
    • Nonprostatic neoplasms did not exhibit positive staining with this method.
    • This represents a novel immunohistochemical marker for prostate gland epithelium.

    Conclusions:

    • Antiserum to human PSA is a valuable diagnostic histologic marker for tumors of prostatic origin.
    • This marker shows high specificity for prostate cancer, differentiating it from other neoplasms.
    • It provides an alternative immunohistochemical tool beyond prostatic acid phosphatase for prostate cancer diagnosis.